SEOM–GEICO clinical guideline on epithelial ovarian cancer (2023)
Guideline
DOI:
10.1007/s12094-024-03531-3
Publication Date:
2024-07-15T14:02:00Z
AUTHORS (10)
ABSTRACT
Abstract In recent years, the incorporation of new strategies to therapeutic armamentarium has completely changed outcomes epithelial ovarian cancer (EOC). The identification predictive and prognostic biomarkers also enabled selection those patients more likely respond targeted agents. Nevertheless, EOC is still a highly lethal disease resistance many these agents common. objective this guideline summarize most relevant manage EOC, help clinician throughout challenging diagnostic processes provide evidence-based recommendations.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....